Streetbeat News

Analyst Ratings

ODFL

Stifel analyst J. Bruce Chan has upgraded Old Dominion Freight Line (NASDAQ:ODFL) from Hold to Buy and announced a price target of $416.

Portfolio Pulse from Benzinga Newsdesk

October 27, 2023 | 9:28 am

RIVN

Cantor Fitzgerald analyst Andres Sheppard has upgraded Rivian Automotive (NASDAQ:RIVN) from Neutral to Overweight and announced a price target of $29.

Portfolio Pulse from Benzinga Newsdesk

October 27, 2023 | 9:09 am

RS

Keybanc analyst Philip Gibbs maintains an Overweight rating on Reliance Steel & Aluminum (NYSE:RS) but lowers the price target from $290 to $285.

Portfolio Pulse from Benzinga Newsdesk

October 27, 2023 | 9:03 am

TSCO

Telsey Advisory Group analyst Joseph Feldman has maintained an 'Outperform' rating on Tractor Supply (NASDAQ:TSCO) but lowered the price target from $245 to $230.

Portfolio Pulse from Benzinga Newsdesk

October 27, 2023 | 8:43 am

EPAM

Piper Sandler analyst Arvind Ramnani maintains a Neutral rating on EPAM Sys (NYSE:EPAM) and raises the price target from $240 to $243.

Portfolio Pulse from Benzinga Newsdesk

October 27, 2023 | 8:35 am

MA

Keybanc analyst Alex Markgraff has maintained an Overweight rating on Mastercard (NYSE:MA) but lowered the price target from $440 to $430.

Portfolio Pulse from Benzinga Newsdesk

October 27, 2023 | 8:30 am

COUR

Keybanc analyst Jason Celino maintains an Overweight rating on Coursera (NYSE:COUR) and raises the price target from $18 to $22.

Portfolio Pulse from Benzinga Newsdesk

October 27, 2023 | 8:24 am

APPF

Keybanc analyst Jason Celino maintains an Overweight rating on AppFolio (NASDAQ:APPF) and raises the price target from $210 to $223.

Portfolio Pulse from Benzinga Newsdesk

October 27, 2023 | 8:22 am

CMG

Keybanc analyst Eric Gonzalez maintains an Overweight rating on Chipotle Mexican Grill (NYSE:CMG) and raises the price target from $2200 to $2250.

Portfolio Pulse from Benzinga Newsdesk

October 27, 2023 | 8:19 am

BSX

Needham analyst Mike Matson has maintained a 'Buy' rating on Boston Scientific (NYSE:BSX) but lowered the price target from $65 to $60.

Portfolio Pulse from Benzinga Newsdesk

October 27, 2023 | 8:09 am